InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Gary B. Gordon
15 May 2026
Director
Buy
10,000
$2.46
$24.60K
David Patience
15 May 2026
Chief Financial Officer
Buy
7,100
$2.43
$17.25K
Mary T Szela
15 May 2026
CEO and President
Buy
39,682
$2.59
$102.78K
Michael P Stansky
15 May 2026
Director
Buy indirect
200,000
$2.50
$500.00K
Michael P Stansky
15 May 2026
Director
Buy
410,000
$2.50
$1.03M
Mats Wahlstrom
15 May 2026
Director
Buy
60,000
$2.53
$151.80K
Michael P Stansky
23 Feb 2026
Director
Buy indirect
117,198
$4.10
$480.51K
Michael P Stansky
23 Feb 2026
Director
Buy
243,900
$4.10
$999.99K
Mary T Szela
23 Feb 2026
CEO and President
Buy
30,487
$4.10
$125.00K
William Valle
23 Feb 2026
Director
Buy
30,487
$4.10
$125.00K
Gary B. Gordon
23 Feb 2026
Director
Buy
9,756
$4.10
$40.00K
David Patience
23 Feb 2026
Chief Financial Officer
Buy
3,657
$4.10
$14.99K
Show all 30 transactions →

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 1,072,287
History held since 28 Dec 2020